Human Brain Project researchers identify new marker of ALS outcome
A new urine test could help curtail the use of the latest synthetic cannabinoids to enter the drug scene
30 September 2022Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors
30 September 2022Human Brain Project researchers identify new marker of ALS outcome
A study by Human Brain Project (HBP) researchers has identified a new marker for predicting the clinical outcome of patients with Amyotrophic Lateral Sclerosis (ALS) through magnetoencephalography. This marker can be measured in the brain during its resting state and highlights the importance of brain flexibility for ALS patients. The study has been led by the Institut de Neurosciences des Systèmes in Marseille, in collaboration with Consiglio Nazionale delle Ricerche, Parthenope University of Naples and Institute of Diagnosis and Care Hermitage Capodimonte in Naples, and the Monash University in Melbourne. It was published online on Sept. 30, 2022, in Neurology.
